Clinical Trials Logo
  1. Home
  2. Postprandial Hypoglycemia
  3. NCT05676385

Glucose Response to a Formula for Patients at Risk of Hypoglycaemia — EFFECT  

Postprandial Hypoglycemia Clinical Trial

Official title:
Glucose Response to a Formula for Patients at Risk of Hypoglycaemia

Clinical Trial Summary

This study assesses the glycemic responses to several nutritional products.

Clinical Trial Description

During a study visit fasted subjects will consume one serving of the reference product or of the test products. Venous blood samples will be taken at baseline and at several time-points over a 6-hr period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05676385
Study type Interventional
Source Nutricia Research
Contact
Status Completed
Phase N/A
Start date February 13, 2023
Completion date March 30, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03984370 - Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass Phase 2
Completed NCT03200782 - Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study N/A
Recruiting NCT05036317 - Empagliflozin for the Treatment of Postprandial Hypoglycemia Phase 3
Active, not recruiting NCT05174507 - Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes Phase 2
Completed NCT04330196 - Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. N/A
Recruiting NCT04720859 - Canagliflozin in Postprandial Hyperinsulinemic Hypoglycemia (CANA-PHH-RYGB) N/A
Completed NCT04836273 - Treatment of Post-bariatric Hypoglycaemia Phase 2
Completed NCT05513404 - The Scottish Fruit Study N/A
Completed NCT01162499 - Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia N/A
Recruiting NCT05401578 - Canakinumab for the Treatment of Postprandial Hypoglycemia Phase 3